ABSTRACT
Introduction:
Robotic approach has shown its feasibility and safety with respect to open approach for radical cystectomy (1). The performances of Hugo™ RAS system (Medtronic, Minneapolis, USA) have been demonstrated in several clinical scenarios (2-5). We report the feasibility and surgical settings of the first series of robot-assisted radical cystectomy (RARC) with intracorporeal ileal-conduit performed with Hugo™ RAS system.
Methods:
Two patients were submitted to RARC with ileal conduit at our institution. The trocar placement scheme and the operating room setting with docking angles of the four arms were already described (6). A 12-mm and a 5-mm trocar for the assistant were placed. In both cases, an ileal-conduit with a Wallace type-1 uretero-enteric derivation was performed intra-corporeally.
Results:
The first patient was a 71-year-old male with a very-high risk non-muscle invasive bladder cancer(BC), and the second patient was a 64-year-old male with a diagnosis of T2 high-grade BC. Operative times were 360 and 420 minutes with a docking time of 12 and 9 minutes, respectively. No intraoperative complications occurred. The estimated blood loss was 200ml and 400ml, respectively. The second patient developed an ileus on postoperative day 4 (Clavien-Dindo grade 2). No positive surgical margins were recorded. No recurrence nor progression occurred during follow-up.
Conclusion:
RARC with intracorporeal ileal conduit urinary diversion is feasible with Hugo™ RAS system. We provided insight into the surgical setting using this novel robotic platform to help new adopters to face this challenging procedure. These findings may help a wider distribution of robotic programs for BC treatment.
Available at: http://www.intbrazjurol.com.br/video-section/20230349_Uleri_et_al
Int Braz J Urol. 2023; 49 (Video #15): 787-8
ACKNOWLEDGEMENTS
Josep Maria Gaya and Alessandro Uleri contributed similarly as first author
REFERENCES
- 1.Fontanet S, Basile G, Baboudjian M, Gallioli A, Huguet J, Territo A, et al. Robot-assisted vs. open radical cystectomy: systematic review and meta-analysis of randomized controlled trials. Actas Urol Esp (Engl Ed) 2023;47:261–270. doi: 10.1016/j.acuroe.2023.01.003. English, Spanish. [DOI] [PubMed] [Google Scholar]
- 2.Gallioli A, Uleri A, Gaya JM, Territo A, Aumatell J, Verri P, et al. Initial experience of robot-assisted partial nephrectomy with Hugo™ RAS system: implications for surgical setting. World J Urol. 2023;41:1085–1091. doi: 10.1007/s00345-023-04336-9. [DOI] [PubMed] [Google Scholar]
- 3.Alfano CG, Moschovas MC, Montagne V, Soto I, Porter J, Patel V, et al. Implementation and outcomes of Hugo(TM) RAS System in robotic-assisted radical prostatectomy. Int Braz J Urol. 2023;49:211–220. doi: 10.1590/S1677-5538.IBJU.2023.9902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ragavan N, Bharathkumar S, Chirravur P, Sankaran S, Mottrie A. Evaluation of Hugo RAS System in Major Urologic Surgery: Our Initial Experience. J Endourol. 2022;36:1029–1035. doi: 10.1089/end.2022.0015. [DOI] [PubMed] [Google Scholar]
- 5.Gaya JM, Uleri A, Gallioli A, Basile G, Territo A, Farré A, et al. Retroperitoneal Robotic Partial Nephrectomy with the Hugo RAS System. Eur Urol. 2023 doi: 10.1016/j.eururo.2023.06.001. S0302-2838(23)02890-7. [DOI] [PubMed] [Google Scholar]
- 6.Territo A, Uleri A, Gallioli A, Gaya JM, Verri P, Basile G, et al. Robotic-assisted oncologic pelvic surgery with HugoTM RAS System: a single-center experience. Asian J Urol in press. doi: 10.1016/j.ajur.2023.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]